Exploratory study on the impact of different doses and route of administration of exogenous progesterone in artificial endometrial preparation cycles on endometrial structure and functio
- Conditions
- Female InfertilityTherapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]
- Registration Number
- CTIS2024-515811-22-00
- Lead Sponsor
- Ivi Valencia S.L.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 108
All women with no history of infertility who agree to participate in the study: 1. Informed consent form (ICF) dated and signed. 2. Age: 18-35 years old , both inclusive 3. Regular menstrual cycles (between 22 and 35 days) 4. In good health and not suffering from any mental or medical condition(s) that would preclude participation in the study
Subjects who meet one or more of the following will not be considered eligible to participate in the pilot study: 1.Simultaneous participation in other clinical studies that, at the researcher's criteria, could interfere with the results of this study. 2.Taking contraceptives in the three months prior to signing informed consent. 3.Presence of uterine pathology (submucosal or intramural myomas >4 cm deforming cavity, endometrial polyps or müllerian anomalies) or adnexal pathology (communicating hydrosalpinx). 4.Background of thrombosis, breast cancer, systemic diseases. 5.Those unable to comprehend the investigational nature of the proposed study.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method